For non-diabetic patients exploring GLP-1 therapy, understanding both your biomarkers (glucose, insulin, lipids) and your genetic context can support a more confident, evidence-informed discussion with your provider about whether this treatment approach is appropriate for you and what outcomes to expect
How Semaglutide is Administered The dosing of semaglutide depends on the condition being treated and whether the medication is being taken as an injection or pill: Injections: Start at a low dose to reduce side effects, then gradually increase
All treatments are supervised by our board-certified medical team
Over time, and with the accumulation of data from these individualized assessments, the dosage of Wegovy (semaglutide) may be increased
Fake products may contain unsafe or unknown ingredients
While GLP-1 receptor agonists and dual GIP/GLP-1 receptor agonists can benefit many patients with type 2 diabetes or obesity, certain individuals face elevated risk for gallbladder complications and require careful consideration before initiating therapy